These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24184699)

  • 21. Evaluation of vitamin D endocrine system (VDES) status and response to treatment of patients in intensive care units (ICUs) using an on-line SPE-LC-MS/MS method.
    Mata-Granados JM; Vargas-Vasserot J; Ferreiro-Vera C; Luque de Castro MD; Pavón RG; Quesada Gómez JM
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):452-5. PubMed ID: 20399267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.
    Giacomini E; Severa M; Rizzo F; Mechelli R; Annibali V; Ristori G; Riccieri V; Salvetti M; Coccia EM
    Eur J Immunol; 2013 Jul; 43(7):1963-72. PubMed ID: 23636665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
    Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
    J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
    Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
    Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unraveling the effects of 1,25OH2D3 on global gene expression in pancreatic islets.
    Wolden-Kirk H; Overbergh L; Gysemans C; Brusgaard K; Naamane N; Van Lommel L; Schuit F; Eizirik DL; Christesen H; Mathieu C
    J Steroid Biochem Mol Biol; 2013 Jul; 136():68-79. PubMed ID: 23137852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis.
    Ramgolam VS; Sha Y; Marcus KL; Choudhary N; Troiani L; Chopra M; Markovic-Plese S
    J Immunol; 2011 Apr; 186(7):4518-26. PubMed ID: 21368231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vitamin D3 on chemokine expression in pulmonary tuberculosis.
    Selvaraj P; Harishankar M; Singh B; Banurekha VV; Jawahar MS
    Cytokine; 2012 Oct; 60(1):212-9. PubMed ID: 22800603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative Evaluation of BAFF, HMGB1, TLR 4 AND TLR 7 Expression in Patients with Relapsing Remitting Multiple Sclerosis.
    Hamid KM; Nejati A; Shoja Z; Mollaei-Kandelousd Y; Doosti R; Mirshafiey A; Tafakhori A; Sahraian MA; Marashi SM
    Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):75-81. PubMed ID: 26996115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunoregulatory role of 1, 25-dihydroxyvitamin D(3)-treated dendritic cells in allergic airway inflammation].
    Xia JB; Wang CZ; Ma JX; An XJ
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):514-8. PubMed ID: 19567068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis.
    Golan D; Staun-Ram E; Glass-Marmor L; Lavi I; Rozenberg O; Dishon S; Barak M; Ish-Shalom S; Miller A
    Brain Behav Immun; 2013 Aug; 32():180-5. PubMed ID: 23665342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
    Jolivel V; Luessi F; Masri J; Kraus SH; Hubo M; Poisa-Beiro L; Klebow S; Paterka M; Yogev N; Tumani H; Furlan R; Siffrin V; Jonuleit H; Zipp F; Waisman A
    Brain; 2013 Apr; 136(Pt 4):1048-66. PubMed ID: 23518712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.
    Zhang X; Tao Y; Wang J; Garcia-Mata R; Markovic-Plese S
    Eur J Immunol; 2013 Jan; 43(1):281-9. PubMed ID: 23076801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered molecular expression of TLR-signaling pathways affects the steady-state release of IL-12p70 and IFN-α in patients with relapsing-remitting multiple sclerosis.
    Deckx N; Willekens B; Wens I; Eijnde BO; Goossens H; Van Damme P; Berneman ZN; Cools N
    Innate Immun; 2016 May; 22(4):266-73. PubMed ID: 27036414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of serum TRAIL level and TRAIL apoptosis gene expression in multiple sclerosis and relation to brain atrophy.
    Tawdy MH; Abd El Nasser MM; Abd El Shafy SS; Nada MA; El Sirafy MN; Magd AH
    J Clin Neurosci; 2014 Sep; 21(9):1606-11. PubMed ID: 24913933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis.
    Stasiolek M; Bayas A; Kruse N; Wieczarkowiecz A; Toyka KV; Gold R; Selmaj K
    Brain; 2006 May; 129(Pt 5):1293-305. PubMed ID: 16513684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: implications for their possible immunopathogenic roles.
    Malmeström C; Andersson BA; Haghighi S; Lycke J
    J Neuroimmunol; 2006 Jun; 175(1-2):176-82. PubMed ID: 16626811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.
    Myrthue A; Rademacher BL; Pittsenbarger J; Kutyba-Brooks B; Gantner M; Qian DZ; Beer TM
    Clin Cancer Res; 2008 Jun; 14(11):3562-70. PubMed ID: 18519790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapse.
    Bartosik-Psujek H; Stelmasiak Z
    Eur Neurol; 2004; 52(4):237-41. PubMed ID: 15550762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
    Krakauer M; Sorensen P; Khademi M; Olsson T; Sellebjerg F
    Mult Scler; 2008 Jun; 14(5):622-30. PubMed ID: 18424480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system.
    Baeke F; Korf H; Overbergh L; van Etten E; Verstuyf A; Gysemans C; Mathieu C
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):221-7. PubMed ID: 20302932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.